Entera Bio (ENTX) Climbs 65% Pre-Open Following EB613 Phase 2 Biomarker Data

March 12, 2021 6:57 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Entera Bio Ltd. (NASDAQ: ENTX) Climbs 65% Pre-Open



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Momentum Movers

Related Entities

Pre Market Movers